Log in to save to my catalogue

How Can Dupilumab Cause Eosinophilic Pneumonia?

How Can Dupilumab Cause Eosinophilic Pneumonia?

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6de0373a93ac457195f3c0b21f6e0279

How Can Dupilumab Cause Eosinophilic Pneumonia?

About this item

Full title

How Can Dupilumab Cause Eosinophilic Pneumonia?

Publisher

Switzerland: MDPI AG

Journal title

Biomolecules (Basel, Switzerland), 2022-11, Vol.12 (12), p.1743

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Reports of eosinophilic pneumonia (EP) as a side effect of dupilumab administration are limited in previous studies. Herein, we report two cases in which EP developed subsequent to the administration of dupilumab for eosinophilic chronic rhinosinusitis (ECRS). Case 1: A 55-year-old woman presented with ECRS, eosinophilic otitis media, and bronchial...

Alternative Titles

Full title

How Can Dupilumab Cause Eosinophilic Pneumonia?

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_6de0373a93ac457195f3c0b21f6e0279

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6de0373a93ac457195f3c0b21f6e0279

Other Identifiers

ISSN

2218-273X

E-ISSN

2218-273X

DOI

10.3390/biom12121743

How to access this item